Core Insights - Oxford Industries reported revenue of $392.86 million for the quarter ended April 2025, reflecting a year-over-year decline of 1.3% and an EPS of $1.82, down from $2.66 a year ago, with a revenue surprise of +1.98% over the Zacks Consensus Estimate of $385.23 million [1] Financial Performance - The company’s net sales for Emerging Brands were $34.20 million, exceeding the average estimate of $33.70 million, representing a year-over-year increase of +3.6% [4] - Net Sales for Lilly Pulitzer reached $99 million, surpassing the two-analyst average estimate of $91.10 million, with a year-over-year change of +12% [4] - Tommy Bahama's net sales were reported at $216.20 million, slightly above the average estimate of $214.30 million, but showed a year-over-year decline of -4.2% [4] - Johnny Was reported net sales of $43.50 million, below the estimated $46.10 million, indicating a year-over-year decrease of -15% [4] Stock Performance - Over the past month, shares of Oxford Industries have returned -6.4%, contrasting with the Zacks S&P 500 composite's +6.9% change, and the stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]
Oxford Industries (OXM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates